The Firm represented the initial purchasers, led by Jefferies LLC, in connection with the Rule 144A and Regulation S offering by AdaptHealth LLC (the “Issuer”), a subsidiary of AdaptHealth Corp. (“AdaptHealth”), of $600 million aggregate principal amount of 5.125% Senior Notes due 2030. The size of the offering was increased from the initially announced offering size of $550 million.
AdaptHealth is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to life and thrive. Product and services offerings include (i) sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) home medical equipment (“HME”) to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home and (v) other HME medical devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
The Simpson Thacher team for the transaction included Art Robinson, David Azarkh, Arielle Katzman, and Rachel Lerman (Capital Markets); Jonathan Cantor and Suzy Yaster (Tax); Jennifer Neilsson (Executive Compensation and Employee Benefits); Vanessa Burrows (Healthcare); Michael Isby (Environmental); Melanie Jolson (Intellectual Property); and Jennie Getsin (Blue Sky).